Scholarlink

Purpose <p>To evaluate the technique of fiducial marker placement to guide cone-beam computed tomography (CBCT) trajectory planning and ablation predictive software for ablation of a segment IVB, biopsy-confirmed, 4.5 × 4.2 × 3.4&#xa0;cm hepatocellular carcinoma in a patient refusing contrast administration.</p> Methods <p>Utilizing ultrasound guidance and fluoroscopic confirmation, six coils were placed at the anatomic margins of the lesion. Following placement, a microwave antenna was advanced under ultrasound and CBCT guidance to abut the first fiducial marker. CBCT was then performed to confirm suitable positioning. Ablation predictive software was utilized to determine the maximal, yet safe, ablation zone for the probe position. This process was repeated at each fiducial marker to encompass the entire lesion with appropriate margins.</p> Results <p>The total fluoroscopic time was 18.5&#xa0;min; the cumulative dose was 1405&#xa0;mGy. There were no intraoperative or immediate complications. The patient experienced mild post-ablation epigastric pain for 1&#xa0;week following the procedure. At 1-month follow-up, the patient had no complaints. The initial post-procedure MRI, and now the most recent 26-month follow-up MRI, demonstrates complete response of the target lesion by mRECIST criteria.</p> Conclusion <p>Ultrasound-guided fiducial marker placement for guidance of cone-beam CT trajectory planning combined with ablation predictive software is a viable technique for ablation of &gt; 3-cm hepatocellular carcinoma when contrast is contraindicated. Future prospective studies are indicated to further evaluate this approach.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Fiducial marker-assisted microwave ablation of hepatocellular carcinoma: achieving margins without contrast

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月21日

查看全文
  • Benjamin Daniel,
  • Brian Kouri

摘要

Purpose

To evaluate the technique of fiducial marker placement to guide cone-beam computed tomography (CBCT) trajectory planning and ablation predictive software for ablation of a segment IVB, biopsy-confirmed, 4.5 × 4.2 × 3.4 cm hepatocellular carcinoma in a patient refusing contrast administration.

Methods

Utilizing ultrasound guidance and fluoroscopic confirmation, six coils were placed at the anatomic margins of the lesion. Following placement, a microwave antenna was advanced under ultrasound and CBCT guidance to abut the first fiducial marker. CBCT was then performed to confirm suitable positioning. Ablation predictive software was utilized to determine the maximal, yet safe, ablation zone for the probe position. This process was repeated at each fiducial marker to encompass the entire lesion with appropriate margins.

Results

The total fluoroscopic time was 18.5 min; the cumulative dose was 1405 mGy. There were no intraoperative or immediate complications. The patient experienced mild post-ablation epigastric pain for 1 week following the procedure. At 1-month follow-up, the patient had no complaints. The initial post-procedure MRI, and now the most recent 26-month follow-up MRI, demonstrates complete response of the target lesion by mRECIST criteria.

Conclusion

Ultrasound-guided fiducial marker placement for guidance of cone-beam CT trajectory planning combined with ablation predictive software is a viable technique for ablation of > 3-cm hepatocellular carcinoma when contrast is contraindicated. Future prospective studies are indicated to further evaluate this approach.